1. Home
  2. NUVB vs BTBT Comparison

NUVB vs BTBT Comparison

Compare NUVB & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • BTBT
  • Stock Information
  • Founded
  • NUVB 2018
  • BTBT 2015
  • Country
  • NUVB United States
  • BTBT United States
  • Employees
  • NUVB N/A
  • BTBT N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • BTBT Finance: Consumer Services
  • Sector
  • NUVB Health Care
  • BTBT Finance
  • Exchange
  • NUVB Nasdaq
  • BTBT Nasdaq
  • Market Cap
  • NUVB 1.1B
  • BTBT 1.1B
  • IPO Year
  • NUVB N/A
  • BTBT 2018
  • Fundamental
  • Price
  • NUVB $3.28
  • BTBT $3.03
  • Analyst Decision
  • NUVB Strong Buy
  • BTBT Strong Buy
  • Analyst Count
  • NUVB 6
  • BTBT 3
  • Target Price
  • NUVB $8.17
  • BTBT $6.33
  • AVG Volume (30 Days)
  • NUVB 6.7M
  • BTBT 21.1M
  • Earning Date
  • NUVB 11-05-2025
  • BTBT 11-17-2025
  • Dividend Yield
  • NUVB N/A
  • BTBT N/A
  • EPS Growth
  • NUVB N/A
  • BTBT N/A
  • EPS
  • NUVB N/A
  • BTBT N/A
  • Revenue
  • NUVB $14,355,000.00
  • BTBT $98,402,256.00
  • Revenue This Year
  • NUVB $332.80
  • BTBT $13.37
  • Revenue Next Year
  • NUVB $360.12
  • BTBT $55.59
  • P/E Ratio
  • NUVB N/A
  • BTBT N/A
  • Revenue Growth
  • NUVB 900.35
  • BTBT 13.30
  • 52 Week Low
  • NUVB $1.54
  • BTBT $1.69
  • 52 Week High
  • NUVB $4.09
  • BTBT $5.74
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 58.18
  • BTBT 57.98
  • Support Level
  • NUVB $3.20
  • BTBT $2.86
  • Resistance Level
  • NUVB $3.41
  • BTBT $3.16
  • Average True Range (ATR)
  • NUVB 0.27
  • BTBT 0.18
  • MACD
  • NUVB -0.03
  • BTBT 0.05
  • Stochastic Oscillator
  • NUVB 33.55
  • BTBT 82.99

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

Share on Social Networks: